Susquehanna International Group
TCRT icon

Susquehanna International Group’s Alaunos Therapeutics TCRT Stock Holding History

Susquehanna International Group’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-931
Closed -$9.87K – 13308
2023
Q4 		$9.87K Buy
931
+113
+14% +$1.36K ﹤0.01% 12075
2023
Q3 		$16.2K Sell
818
-2,442
-75% -$105K ﹤0.01% 11651
2023
Q2 		$249K Sell
3,260
-766
-19% -$62K ﹤0.01% 9817
2023
Q1 		$380K Buy
4,026
+772
+24% +$73.5K ﹤0.01% 9195
2022
Q4 		$317K Sell
3,254
-5,280
-62% -$765K ﹤0.01% 8959
2022
Q3 		$2.2M Buy
8,534
+869
+11% +$252K ﹤0.01% 4718
2022
Q2 		$1.43M Buy
7,665
+5,242
+216% +$501K ﹤0.01% 5674
2022
Q1 		$237K Sell
2,423
-2,915
-55% -$374K ﹤0.01% 10834
2021
Q4 		$873K Sell
5,338
-1,396
-21% -$307K ﹤0.01% 7644
2021
Q3 		$1.84M Buy
6,734
+1,001
+17% +$306K ﹤0.01% 6017
2021
Q2 		$2.27M Buy
5,733
+1,938
+51% +$905K ﹤0.01% 5632
2021
Q1 		$2.05M Sell
3,795
-3,558
-48% -$2.22M ﹤0.01% 5854
2020
Q4 		$2.78M Sell
7,353
-350
-5% -$139K ﹤0.01% 4434
2020
Q3 		$2.91M Buy
7,703
+1,197
+18% +$529K ﹤0.01% 3908
2020
Q2 		$3.2M Sell
6,506
-781
-11% -$348K ﹤0.01% 3697
2020
Q1 		$2.68M Sell
7,287
-7,479
-51% -$3.87M ﹤0.01% 3471
2019
Q4 		$10.5M Buy
14,766
+7,755
+111% +$5.34M ﹤0.01% 2036
2019
Q3 		$4.5M Buy
7,011
+21
+0.3% +$16.7K ﹤0.01% 2871
2019
Q2 		$6.11M Sell
6,990
-1,093
-14% -$752K ﹤0.01% 2449
2019
Q1 		$4.67M Sell
8,083
-513
-6% -$214K ﹤0.01% 2541
2018
Q4 		$2.41M Buy
8,596
+4,194
+95% +$1.66M ﹤0.01% 3247
2018
Q3 		$2.11M Sell
4,402
-803
-15% -$344K ﹤0.01% 3888
2018
Q2 		$2.36M Sell
5,205
-905
-15% -$574K ﹤0.01% 3744
2018
Q1 		$3.59M Sell
6,110
-4,883
-44% -$3.04M ﹤0.01% 2972
2017
Q4 		$6.83M Sell
10,993
-23,435
-68% -$16.8M ﹤0.01% 2185
2017
Q3 		$31.7M Sell
34,428
-18,217
-35% -$16.2M 0.01% 918
2017
Q2 		$49.1M Buy
52,645
+48,800
+1,269% +$47.8M 0.02% 620
2017
Q1 		$3.66M Sell
3,845
-8,288
-68% -$7.72M ﹤0.01% 2732
2016
Q4 		$9.74M Buy
12,133
+2,523
+26% +$2.27M ﹤0.01% 1584
2016
Q3 		$8.12M Sell
9,610
-600
-6% -$482K ﹤0.01% 1697
2016
Q2 		$8.41M Sell
10,210
-1,109
-10% -$1.21M ﹤0.01% 1606
2016
Q1 		$12.6M Sell
11,319
-8,621
-43% -$8.82M 0.01% 1349
2015
Q4 		$24.9M Buy
19,940
+5,329
+36% +$8.81M 0.01% 988
2015
Q3 		$19.7M Buy
14,611
+4,397
+43% +$7.26M 0.01% 1215
2015
Q2 		$18.4M Buy
10,214
+6,157
+152% +$9.56M 0.01% 1380
2015
Q1 		$6.55M Sell
4,057
-266
-6% -$394K ﹤0.01% 2367
2014
Q4 		$3.29M Buy
4,323
+367
+9% +$195K ﹤0.01% 3577
2014
Q3 		$1.57M Buy
3,956
+275
+7% +$133K ﹤0.01% 5055
2014
Q2 		$2.23M Buy
3,681
+1,830
+99% +$1.02M ﹤0.01% 4458
2014
Q1 		$1.27M Sell
1,851
-6,465
-78% -$4.33M ﹤0.01% 5092
2013
Q4 		$5.41M Buy
8,316
+3,917
+89% +$2.33M ﹤0.01% 2837
2013
Q3 		$2.61M Buy
4,399
+222
+5% +$100K ﹤0.01% 3694
2013
Q2 		$1.31M Buy
+4,177
New +$1.16M ﹤0.01% 4556

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

Susquehanna International Group's TCRT Position: Q1 2024 in Review

Susquehanna International Group sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 931 shares — an estimated $9.87K sold.

Susquehanna International Group first reported a position in TCRT in Q2 2013 and held it in 43 quarters. The position peaked at $49.1M in Q2 2017. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.

  • Susquehanna International Group reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 931 Alaunos Therapeutics shares in Q1 2024, an estimated $9.87K.
  • Susquehanna International Group first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 43 quarters.
  • Susquehanna International Group's Alaunos Therapeutics position peaked at $49.1M in Q2 2017.
  • 45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.